Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Barakat Foundation is a prominent Iranian charitable foundation and a major player in the country's pharmaceutical and healthcare sectors. As a subsidiary of the Execution of Imam Khomeini's Order (EIKO), it oversees the Barkat Pharmaceutical Group, which controls a significant portion of Iran's medicinal supply chain. The foundation gained global recognition for developing COVIran Barekat, the first Iranian-made COVID-19 vaccine, through its subsidiary Shifa Pharmed. It also manages the Barkat Pharmaceutical Industrial Town, a large-scale hub designed to foster pharmaceutical research and production. The organization's primary mission is to achieve national self-sufficiency in essential medicines, including oncology drugs and biotechnological products. Through its various subsidiaries, the foundation is involved in the entire value chain from research and development to manufacturing and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Barakat Foundation.